David Tapolczay - 18 Nov 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Chief Executive Officer, Director
Signature
/s/ David Tapolczay
Issuer symbol
CDT
Transactions as of
18 Nov 2024
Net transactions value
+$77,196
Form type
4
Filing time
20 Nov 2024, 16:30:09 UTC
Previous filing
24 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDT Stock Option (Right to Buy) Award $77,196 +840,000 $0.0919 840,000 18 Nov 2024 Common Stock 840,000 $0.0919 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan.
F2 The Options vest as follows: (i) 50% on the grant date and (ii) 50% in equal annual installments on the first three anniversaries of the grant date.